Crisaborole

Dipharma manufactures wide range of Active Pharmaceutical Ingredients which includes Aminocaproic Acid. It belongs to new products category. Therapeutic category: Treatment of bleeding disorders. Contact us for more information.

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Amitriptyline Hydrochloride. It belongs to commercial products category. Therapeutic category: Antidepressant. Contact us for more information.

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Benserazide Hydrochloride. It belongs to new products category. Therapeutic category: Antiparkinson. Contact us for more information.

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Biperiden Hydrochloride. It belongs to new products category. Therapeutic category: Antiparkinson. Contact us for more information.

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Bupropion Hydrochloride. It belongs to commercial products category. Therapeutic category: Antidepressant. Contact us for more information.

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Chenodeoxycholic Acid*. It belongs to new products category. Therapeutic category: Bile Stone Therapy, Plain antitussives. Contact us for more information.

* only for specific markets. See our web site

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Cyclobenzaprine Hydrochloride. It belongs to commercial products category. Therapeutic category: Muscle Relaxant. Contact us for more information.

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Dapsone. It belongs to new products category. Therapeutic category: Antibacterial. Contact us for more information.

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Dexlansoprazole Anhydrous Crystalline. It belongs to new products category. Therapeutic category: Antiulcerative. Contact us for more information.

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Diclofenac Potassium. It belongs to commercial products category. Therapeutic category: Anti-inflammatory. Contact us for more information.

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Diclofenac Sodium. It belongs to commercial products category. Therapeutic category: Anti-inflammatory. Contact us for more information.

Dipharma manufactures wide range of active pharmaceutical ingredients which includes Dothiepin Hydrochloride (Dosulepin HCl). It belongs to commercial products category. Therapeutic category: Antidepressant. Contact us for more information.

The Company strengthens its analytical R&D capabilities, to better support its customers operating in the CDMO and Generics market.

The Company continues to strengthen its capabilities in the North American market

The Baranzate site (Italy) is the first Dipharma manufacturing facilityto receive Anvisa certification

Thanks to the approval by the Italian Medicines Agency (AIFA),the Company increases its efficiency and is able to face the growing demand for its services

EcoVadis has rated Dipharma Francis’s performance among the top 25% of all organizations surveyed.

The merger represents the last step of Kalexsyn’s integration into the Dipharma Group

Kalexsyn Inc. announced that its Board of Directors appointed Brian Eklov to succeed Robert Gadwood, who is retiring, as Chief Executive Officer and Board member.

The new plant brings significant positive impact on the environment and sustainable development

Received 468 White Certificates

Italy’s Dipharma Francis has completed construction of a new cGMP manufacturing suite at its US subsidiary, Kalexsyn, strengthening its service offering and ensuring continuity across the product lifecycle from preclinical to commercialisation , the contract research and development organization announced Monday.

Dipharma Francis S.r.l., (Dipharma), a leading European manufacturer of Active Pharmaceutical Ingredients, announced a series of changes in the leadership positions following the retirement of Mrs. Barbara Geinoz-Biazzi, Chairman.